Detail akcie Sartorius AG Preferred Stock online

Business Summary: Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Sartorius AG revenues decreased 19% to EUR3.4B. Net income applicable to common stockholders decreased 70% to EUR205.2M. Revenues reflect Bioprocess Solutions segment decrease of 19% to EUR2.68B, Lab Products and Services segment decrease of 15% to EUR717.5M, United States (Country) segment decrease of 19% to EUR1.16B, China (Country) segment decrease of 41% to EUR276.5M.